Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > New Question - Restructuring
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Health123on Mar 19, 2017 7:56am
177 Views
Post# 25998849

RE:RE:RE:RE:RE:RE:RE:New Question - Restructuring

RE:RE:RE:RE:RE:RE:RE:New Question - Restructuring
What I posted It was taken directly from the earnings transcripts, so I am not sure why you are trying to deceive the people here.  You can stil listen to the eartnings call on the Concordia webcast and the question was the first question asked in the Q&A 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities